Home

KLEINER PERKINS CAUFIELD & BYERS X A LP

CIK 1118829 · last filed 2018-07-31

KLEINER PERKINS CAUFIELD & BYERS X A LP is a corporate insider who has filed 5 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for BE, was dated Jul 31, 2018. The firm reports its address in Menlo Park, CA. 8 SEC filings were submitted jointly with KLEINER PERKINS CAUFIELD & BYERS X B LP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

5

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
2750 SAND HILL RD
MENLO PARK, CA 94025
State of Incorporation
CA
Related Filers
KLEINER PERKINS CAUFIELD & BYERS X B LP — 8 joint filings, latest 2019-11-26
KPCB X ASSOCIATES LLC — 8 joint filings, latest 2019-11-26
KLEINER PERKINS CAUFIELD & BYERS IX A LP — 6 joint filings, latest 2019-11-26
KLEINER PERKINS CAUFIELD & BYERS IX B LP — 6 joint filings, latest 2019-11-26
KPCB IX ASSOCIATES LLC — 6 joint filings, latest 2019-11-26
KPCB PANDEMIC & BIO DEFENSE FUND LLC — same reported address
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BE 10%+ Owner — $275.75 — $0 1 2018-07-31
ArcSight Inc (ARST) Delisted 10%+ Owner 1,207,162 — — $0 3 2010-06-28
Orexigen Therapeutics, Inc. (OREX) Delisted 10%+ Owner 195,062 — — $0 1 2007-05-03

Recent Filings

5 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2018-07-31 BE Conv (C) — $0 EDGAR
2010-06-28 ArcSight Inc (ARST) Delisted Other (J) −402,388 $0 EDGAR
2009-06-25 ArcSight Inc (ARST) Delisted Other (J) −402,388 $0 EDGAR
2008-02-22 ArcSight Inc (ARST) Delisted Conv (C) +1,567,143 $0 EDGAR
2007-05-03 Orexigen Therapeutics, Inc. (OREX) Delisted Conv (C) +2,575,573 $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.